Continuous glucose monitors
Dexcom G6 | Dexcom G7 | Freestyle Libre 2 | Freestyle Libre 2 Plus | Freestyle Libre 3 | Eversense E3 | Guardian Connect | |
---|---|---|---|---|---|---|---|
Maximum wear time (days) | 10 | 10.5 | 14 | 15 | 14 | 180 | 7 |
Warm-up time | 2 hours | 30 minutes | 1 hour | 1 hour | 1 hour | 24 hours | Up to 2 hours |
MARD4–7,10,13 | 9% | 8.2% | 9.2% | 8.2% | 7.9% | 8.5% | 9% (arm), 10.5% (abdomen) |
Calibrations required | 0 | 0 | 0 | 0 | 0 | 2 per day for 21 days, then 1 per day | 2 per day |
Integrationa with insulin pumps, smart pens, caps, buttons | t:slim X2, Omnipod 5, iLet, Tempo Smart Button | InPen (available only for Apple iOS), t:slim X2, iLet, Tempo Smart Button | Bigfoot Unity smart cap | t:slim X2 | Insulin pumps FDA-cleared but not yet available | None | None |
Display device | Smartphone or reader | Smartphone or reader | Smartphone or reader | Smartphone or reader | Smartphone or reader | Smartphone only | Smartphone only |
Drug interactions | Hydroxyurea | Hydroxyurea | Vitamin C > 500 mg | Vitamin C > 1,000 mg | Vitamin C | Tetracycline antibiotics, mannitol | Acetaminophen, hydroxyurea |
FDA-cleared sites | Abdomen | Upper arm | Upper arm | Upper arm | Upper arm | Upper arm | Upper arm, abdomen |
Approved in pregnancy | No | Yes | Yes | Yes | Yes | No | No |
↵aIntegration is the communication ability between the glucose monitor sensor and pump or other device.
FDA = US Food and Drug Administration; MARD = mean absolute relative difference
Based on information from references 4–13.